Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Eloralintide

ENLIGHTEN-3

Eli Lilly · Phase 3 · Recruiting · Enrollment 800

NCT07369011

ArmPopulationDoseWeeksEstimandWeight change
Eloralintide (YSA1)Obesity or overweightn/r76n/rn/r
Placebo (YSA1)Obesity or overweightn/r76n/rn/r
Eloralintide (YSA2)Obesity or overweightn/r76n/rn/r
Placebo (YSA2)Obesity or overweightn/r76n/rn/r